Foto del docente

Patrizia Hrelia

Full Professor

Department of Pharmacy and Biotechnology

Academic discipline: BIO/14 Pharmacology

Director of Single Cycle Degree in Pharmacy

Curriculum vitae

 ACADEMIC CAREER

Full Professor of Pharmacology, University of Bologna (2001-present)

Associate Professor of Pharmacology, University of Bologna (1998 - 2001)

Assistant Professor, University of Bologna (1990 - 1997)

Visiting Assistant Professor at the University of Texas Medical Branch, Galveston (TX) USA (1987-1988)

PhD in Cell Biology, University of Bologna (1986)

Laurea cum laude in Medicinal Chemistry, Faculty of Pharmacy, University of Bologna- 110/110 cum laude.

PROFESSIONAL EXPERIENCES

Head of Laboratory of Predictive Toxicology, FaBiT, University of Bologna

Director of Single Cycle Degree in Pharmacy (2018-present)

Coordinator of the PhD Program in Pharmacology and Toxicology, Human Development and Movement Sciences, University of Bologna (2013-2019).

Head of the Department of Pharmacology (2009-2012)

Director of the post-graduate School in Toxicology (2003-2005)

HONOURS AND AWARDS

Eurotox Registered Toxicologist whilst registered with the Italian Register of Toxicologists (2001-present)

Adjunct Professor at the University of Texas Medical Branch, Galveston (TX), USA (2012-2014)

Adjunct Associate Professor at the University of Texas Medical Branch, Galveston (TX) USA (1991-2012)

LEARNED SOCIETIES AND BOARDS

National Scientific Qualification Parallel Committee, MIUR, member (2019-present)

SITOX, the Italian Society of Toxicology, Past President (2018-2022).

Bioethic committee, Repubblica S. Marino, Board member (2020-present)

Fondazione Cassa di Risparmio Bologna e Ravenna, Board member addressing scientific research (2019-present)

Accademia Nazionale Agricoltura, Academic member (2018-present)

Fondazione Famiglia Parmiani, Board member (2018-present)

Accademia Nazionale Agricoltura, Corresponding academic member (2015-2018)

SITOX, Italian Society of Toxicology, President (2015-2018)

ERT, Italian Registry of Toxicologist within EUROTOX (European Society of Toxicology), President (2011-2015).

SITOX, Italian Society of Toxicology, President elect, (2012-2014)

SIF, Italian Society of Pharmacology, Councilor, (2009-2012; 2018-present).

Codex Alimentarius of the Italian Ministry of Agriculture Working group on Contaminants, member (2009-2015).

University of Bologna, Executive Committee and Master Thesis Supervisory Committee, Graduate School in Biological, Biomedical, and Biotechnological Sciences, member (2006-2015).

University of Bologna, Graduate Program in Pharmacology and Toxicology, Faculty, member (2006-2015).

University of Bologna, Department of Pharmacy and Biotechnology, Board of Regents, member (2012-2015; 2019-2021);

University of Bologna, Committee for Scientific Research, Faculty of Pharmacy, member (2005-2012).

University of Bologna, Faculty, Graduate Program in Pharmaceutical Sciences, member (1999-2006).

University of Bologna, Committee for Environmental Protection, member (1996-1998).

REVISION PANELS

University of Tromsø (UiT) – The Arctic University of Norway

Serra Húnter Selection Committees, University of Catalunya, Spain

National Research Council (CNR)

Italian Ministry for University and Research (MIUR)

The Philip Morris Company (USA)

BMRC of Singapore

The University of Texas Medical Branch (UTMB) USA

Register of Expert Peer Reviewers for Italian Scientific Evaluation, MIUR

University of Trieste

 

ORGANIZATIONAL ACTIVITIES

Collaborations with numerous international academic and government laboratories.

Large scientific and administrative experience in organizing national and international meetings.

Chaired several Scientific Sessions in International and National Meetings.

FUNDING (National and International grants)

PNRR-CN3 National Center for Gene Therapy and Drugs based on RNA Technology (CN RNA & Gene Therapy).

PNRR-PE12: MNESYS, Neuroscienze e neurofarmacologia.

PRIN PNRR (MIUR Italy)

PRIN (MIUR Italy)

EU FP7 KBBE

EU-FP7-SME-2007-1

FIRB  (MIUR, Italy)

Fondazione del Monte di Bologna e Ravenna (Italy)

Fondazione Cassa di Risparmio di Bologna (Italy) 

MIPAF (Italy)

PRIN ex 40% (MIUR Italy)

PATENTS

RM2007A000668 - COMBINATION BETWEEN AN ISOTHIOCYANATE AND LEVODOPA FOR PARKINSON'S

DISEASE TREATMENT in collaboration with Tarozzi A, Morroni F and Cantelli Forti G.

RESEARCH INTERESTS

Authored over 220 articles published in peer reviewed journals. Her H-index is 42. The research philosophy is a multidisciplinary approach to problems of preventive and traslational medicine.

The research is guided by three main objectives, which compliment the scientific mission, namely:

1) Multifunctional therapeutic strategies for chemoprevention of cancer and neuroprotection

2) Development of new cellular and molecular approaches in vitro and in vivo to detect and quantify the global cellular response to toxic stress.

3) Development of methods based on biomarker analysis to improve assessment of human early biological response, susceptibility and risk.

OUTREACH AND DISSEMINATION

 Patrizia Hrelia always played a role in the establishment and consolidation of European pharmaco-toxicological research area, as testified by her election as President of the Italian Society of Toxicology and President of the Italian Registry of Toxicologist within the European Society of Toxicology, and as a board member of the Italian Society of Pharmacology.

EDITORIAL AND REFEREE ACTIVITIES

Editorial Board Members of section "Bioactives and Nutraceuticals" International Journal of Molecular Sciences. Journal Reviewer for several international journals. 

Latest news

At the moment no news are available.